Abstract 6931: Epigenetic Modification of the Von Willebrand Factor Promotor Drives <i>in situ</i> Thrombosis in Chronic Thromboembolic Pulmonary Hypertension
Xue D. Manz, Harm Jan Bogaard(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jisca Majolée(Amsterdam University Medical Centers), Peter L. Hordijk(University of Amsterdam), Reinier A. Boon(Goethe University Frankfurt), Robert Szulcek(Leiden University Medical Center), Sander R. Piersma(Amsterdam UMC Location Vrije Universiteit Amsterdam), Xiaoke Pan, Veerle Kremer(Amsterdam University Medical Centers), Teodora Radonic(Vrije Universiteit Amsterdam), Jurjan Aman(Amsterdam Neuroscience), Irene V. Bijnsdorp(Amsterdam UMC Location Vrije Universiteit Amsterdam), Elisabetta Michielon(University Medical Center), Petr Symersky, Ekatarina S Jordanova, Jan Voorberg(Sanquin), Connie R. Jiménez(Amsterdam UMC Location Vrije Universiteit Amsterdam), Chris Dickhoff(Amsterdam Neuroscience), Frances S. de Man(Amsterdam Neuroscience), Thang V. Pham(Oncode Institute)
Cited by 0
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Nontemplated Nucleotide Additions Distinguish the Small RNA Composition in Cells from Exosomes
|Cell Reports|2014|592
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
|Science|2020|415
Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles
|Journal of Extracellular Vesicles|2021|410